We would love to hear your thoughts about our site and services, please take our survey here.
It has all the signs
https://www.griproom.com/fun/10-signs-your-stock-is-being-manipulated
https://www.trademarkelite.com/australia/trademark/trademark-detail/2155208/AffiDX
Investor webinar - Questions and answers! They dont have to do this do they?
An investor webinar presentation by Alastair Smith, Chief Executive Officer and Tony Gardiner, Chief Financial Officer, will take place at 10:30am BST on Thursday, 30 September 2021.
The webinar is open to all existing and potential investors and will consist of a presentation followed by a Q&A session, held on the Investor Meet Company platform. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and then click “Add to meet” Avacta Group via the following link to join the webinar:
https://www.investormeetcompany.com/avacta-group-plc/register-investor
Investors who already follow Avacta Group plc on the Investor Meet Company platform will automatically be invited.
Investor webinar - they don't have to do this!!
An investor webinar presentation by Alastair Smith, Chief Executive Officer and Tony Gardiner, Chief Financial Officer, will take place at 10:30am BST on Thursday, 30 September 2021.
The webinar is open to all existing and potential investors and will consist of a presentation followed by a Q&A session, held on the Investor Meet Company platform. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and then click “Add to meet” Avacta Group via the following link to join the webinar:
https://www.investormeetcompany.com/avacta-group-plc/register-investor
Investors who already follow Avacta Group plc on the Investor Meet Company platform will automatically be invited.
The company has alot going for it, and we will all find out one way or another by the 30th. Why de-ramp it now, patients is required for a couple of weeks ! I think it probably to do with the cancer drug as a cycle takes 6 weeks for chemo and this is just after that.
MEDUSA WEBSITE - COMING SOON !! Currently under development !!
Avacta Antigen Test
Medusa 19 has entered into a distribution agreement with Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, for its COVID-19 rapid antigen test that is currently under development.
This agreement provides Medusa 19 with exclusive distribution rights to consumers and non-exclusive distribution rights to businesses.
The test will indicate whether an individual has the COVID-19 infection and is intended to provide a result within minutes.
See more on the Avacta site or via our news section.
COMING SOON
It's a pity they can't get together with biontechs new clinical cancer trials as there drug has issues pin pointing the cancer and are putting it straight into the cancer due to toxicity. Avacters new approach could change everything.
Sorry i'm new here. I bet avacta is a little scraed of a premature takeover bid before the products and maybe test results are fully matured. I think the business could be grown very substatially, but they need to be cautious with there news and when they deliver it. I think this company is going places, not just for the share price and I hope they succeed.